Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of 'stemness' programs and local inflammation
Nagaraju, R. T.
Burghel, G. J.
Wallace, A. J.
Braun, Michael S
Evans, D. G.
Bristow, Robert G
Saunders, Mark P
O'Dwyer, Sarah T
AffiliationDivision of Cancer Sciences. Faculty of Biology, Medicine and Health, University of Manchester
MetadataShow full item record
AbstractPurpose: At diagnosis, colorectal cancer presents with synchronous peritoneal metastasis in up to 10% of patients. The peritoneum is poorly characterized with respect to its super-specialised microenvironment. Our aim was to describe the differences between peritoneal metastases and their matched primary tumours excised simultaneously at the time of surgery. Also, we tested the hypothesis of these differences being present in primary colorectal tumours and having prognostic capacity. Experimental design: We report a comprehensive analysis of thirty samples from peritoneal metastasis with their matched colorectal cancer primaries obtained during cytoreductive surgery. We tested and validated the prognostic value of our findings in a pooled series of 660 colorectal cancer primary samples with overall survival (OS) information and 743 samples with disease free survival (DFS) information from publicly available databases. Results: We identified 20 genes dysregulated in peritoneal metastasis that promote an early increasing role of 'stemness' in conjunction with tumour favourable inflammatory changes. When adjusted for age, gender and stage, the 20-gene peritoneal signature proved to have prognostic value for both OS (adjusted-hazard ratio (HR) for the high-risk group (vs low-risk) 2.32 (95% confidence interval (CI) 1.69-3.19; p-value < 0.0001)) and for DFS (adjusted-HR 2.08 (95%CI 1.50-2.91; p-value < 0.0001)). Conclusions: Our findings indicated that the activation of "stemness" pathways and adaptation to the peritoneal specific environment are key to early stages of peritoneal carcinomatosis. The in-silico analysis suggested that this 20-gene peritoneal signature may hold prognostic information with potential for development of new precision medicine strategies in this setting.
CitationBarriuso J, Nagaraju RT, Belgamwar S, Chakrabarty B, Burghel GJ, Schlecht H, et al. Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of Stemness Programs and Local Inflammation. Clin Cancer Res. 2020.
JournalClinical Cancer Research
- Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
- Authors: Narasimhan V, Britto M, Pham T, Warrier S, Naik A, Lynch AC, Michael M, Tie J, Ramsay R, Heriot A
- Issue date: 2019 Oct
- Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
- Authors: Ljunggren M, Nordenvall C, Palmer G
- Issue date: 2021 Nov
- Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
- Authors: Sluiter NR, Rovers KP, Salhi Y, Vlek SL, Coupé VMH, Verheul HMW, Kazemier G, de Hingh IHJT, Tuynman JB
- Issue date: 2018 Aug
- Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
- Authors: Flood MP, Das AA, Soucisse ML, Kong J, Ramsay RG, Michael M, Loveday BPT, Warrier SK, Heriot AG
- Issue date: 2021 Jun 1
- Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study.
- Authors: Flood MP, Waters PS, Kelly ME, Shields C, Conneely J, Ramsay R, Michael M, Loveday B, Warrier SK, Mulsow J, Heriot AG
- Issue date: 2021 Jun